Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Brain tumor, adult: Meningioma/Meningeal tumors
Trial Type:  Treatment
Results 1-12 of 12 for your search:
Start Over
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BMX-HGG-001, NCI-2016-00288, NCT02655601
Increased Dose IMPT in Treating Patients with High-Grade Meningiomas
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 15-542, NCI-2016-00702, NCT02693990
Proton Beam Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma or Hemangiopericytoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 24309, NCI-2010-01084, NCT01117844
Laboratory Treated T-Cells in Treating Patients with NY-ESO-1 Expressing Metastatic or Locally Advanced Recurrent Solid Tumors, Melanoma, or Malignant Meningioma
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 13-C-0214, NCI-2015-00137, 130214, 1308-1249, P131300, RD-13-VII-07, NCT01967823
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LOXO-TRK-15002, NCI-2015-01947, NCT02576431
Nivolumab in Treating Adult Patients with Recurrent High-Grade Meningioma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-490, NCI-2016-00504, NCT02648997
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients with Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NU 16C02, NCI-2016-01026, STU00203030, NCT02847559
Vistusertib in Treating Patients with Neurofibromatosis Type 2 and Progressive or Symptomatic Meningioma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 15-590, NCI-2016-01372, NCT02831257
Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Recurrent or Refractory Tumors in the Brain and/or Spinal Cord
Status: Active
Phase: Phase I
Type: Treatment
Age: Any age
Trial IDs: 03-133, NCI-2016-00928, MSKCC-03133, NCT00089245
Everolimus in Patients with Vestibular Schwannomas or Meningiomas Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NYU S12-02808, NCI-2013-01174, 13211666, i12-02808, S12-02808, NCT01880749
Electric Field Therapy in Treating Patients with Recurrent Meningioma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 13-067, NCI-2013-01316, NCT01892397
Mifepristone in Treating Patients With Cancer
Status: Enrolling by invitation
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: INST 0817, NCI-2011-02682, NCT00832871
Start Over